1st EHA-Balkan Hematology Day
EHA is joining forces with the national societies from the Balkan countries and co-organizing with them the 1st edition of the EHA-Balkan Hematology Day. The meeting will take place during the Bulgarian Medical Society of Hematology Congress in Pravets (Bulgaria) and will focus on education and research in a few selected areas of hematology.
Dates: October 11, 2019
Location: Pravets, Bulgaria
Prof John Gribben, President, European Hematology Association (EHA)
Prof Gert Ossenkoppele, Chair EHA Education Committee
Prof Gianluca Gaidano, Chair EHA Global Outreach Program Unit
Prof Margarita Guenova, Representative Balkan Societies
At EHA we highly value international collaboration, and we aim to foster long-term relations with our national society partners. EHA is teaming up with the national societies of the Balkan region on the previously existing Balkan Hematology Day, and transforming the program by bringing in experts from other European countries.
We will kick off this collaboration with the first 1st EHA-Balkan Hematology Day, which will be hosted by the Bulgarian Medical Society of Hematology. This full-day meeting will focus on lymphoid malignancies and CAR T cell therapy, with lectures by international experts and cases presented by regional speakers.
The EHA-Balkan Hematology Day program will focus on lymphoid malignancies and CAR T and the following main topics will be covered:
- Acute myeloid leukemia
- Acute lymphoblastic leukemia
- CAR T cells
For the full meeting program, click here.
Physicians, clinicians, basic researchers, biologists, trainees, medical students from the Balkan region.
Travel grants will be available. More information will be announced soon.
Hotel RIU Pravets
Quarter Ezeroto, 8
2161 Pravets, Bulgaria
Registration information will follow shortly.
EBAH CME Accreditation
The 1st EHA-Balkan Hematology Day is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.